ArticleOncoTargets and therapy2017

miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4.

Haili Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.